Why this mushroom is an emerging threat

[ad_1]

<div _ngcontent-c14 = "" innerhtml = "

There is nothing fun about this mushroom that is a yeast.

Candida auris& nbsp; can, has, and continues to spread to hospitals around the world. It can stay long enough on skin and objects, such as furniture and hospital equipment. Thus, it can be transmitted indirectly from one patient to the other. It can invade your body and kill you if your immune system is weakened. It can be resistant to the three main categories of antifungal medications, leaving little choice for physicians. C. auris& nbsp; infections.

Therefore, candi-do not take lightly what the The Centers for Disease Control and Prevention (CDC) have named "emerging global threat. "To the yeast, find out more about this yeast.

To get an idea of ​​the difficulty Candida auris& nbsp;maybe, take a look at & nbsp;a study published last year in the journal Emerging infectious diseases. & nbsp; This study & nbsp;examined 51 cases of & nbsp;C. auris& nbsp; infections occurred in New York health facilities from 2016 to 2018. All patients already had serious health problems prior to infection and were between 21 and 96 years old. & nbsp; Nearly half (45 years)%) of patients eventually died within 90 days of diagnosis C. auris& nbsp; infections. Almost all (98%) of C. auris& nbsp; Samples from 50 patients were resistant to fluconazole, a commonly used antifungal drug. Testing different objects and rooms revealed C. auris& nbsp; in the environments of & nbsp;15 of the 20 health facilities.

Typically, C. auris& nbsp;infections occur after a patient in a health facility for several weeks. The most commonly reported infections include wounds, blood circulation and ears. Doctors have found the fungus in the urine and the respiratory tract of people, but it is unclear if the fungus extends into these places without causing problems. For the moment, if your immune system is strong, your chances of getting a & nbsp; representing a danger of deathC. auris& nbsp;infections & nbsp; are very weak. The risk increases if you have a chronic illness like& nbsp; diabetes mellitus or have undergone recent surgery, recent antibiotic therapy or a central venous catheter. However, as Sarah Connor said in the terminator, the future is unknown. Who knows if a day & nbsp;C. auris& nbsp; will it also be a threat to healthy people?

In June 2016, the CDC issued an alert to health facilities about this growing threat. The first official case of C. auris, was produced in Japan in 2009. & nbsp; & nbsp; Since then, & nbsp;C. auris has appeared in many countries, including South Korea, India, South Africa, Kuwait, Colombia, Venezuela, Pakistan, the United Kingdom and the United States.

The question is, however, whether health facilities talk about their health?Candida auris problems? Not as sincere as they could be, according to what Matt Richtel and Andrew Jacobs wrote for the New York Times. Their article described what happened when the Royal Brompton Hospital in London realized that it had a C. auris& nbsp; problem in 2015. While the hospital had alerted the UK government and infected patients, the hospital "did not make any public announcement." (At yeast, they told infected patients.) As Richtel and Jacobs wrote, "Individual institutions and national, state, and local governments have been reluctant to announce epidemics of resistant infections, claiming that they are not safe. it is useless to scare patients – or potential patients. "

Uh, no need to scare patients? It's like saying that there is no point in letting people looking to look at Shazam know that there is currently a free tiger in a movie theater. You have the right to know something that can kill you or your loved ones. When choosing a health facility, the facility's ability to prevent and control infections should be a determining factor. After all, would you go to a pizzeria known for diarrhea while her pizza is delicious?

Health institutions may take measures to control the spread of C. auris. & nbsp; Detection and rapid diagnosis of this fungus are important. It's not always easy since C. auris can be confused with other types of candida species. Once a patient is diagnosed with C. auris, the health facility should place the patient in a separate room as soon as possible. Everyone entering the room should take precautions, including wearing disposable gloves and gowns. It is also essential that healthcare facilities equipped with C. auris regularly cleanse and disinfect the rooms of the patients concerned with special cleaning agents known for their action against fungi. The Environmental Protection Agency (EPA) has a list of these cleaners.

Much of the fight against antimicrobial resistant organisms has been focused on antimicrobial resistant & nbsp;bacteria. However, it is not enough to catch your bacteria. The emergence of resistant drugs & nbsp;C. auris& nbsp; reminds that other microbes can also become resistant to our available weapons. Candidiasis,& nbsp; in general, may be better known to cause diaper rash. Do not take a more urgent approach to treating & nbsp;C. auris& nbsp; would not only be reckless, but would also let us dive into what you will often find in diapers. & nbsp; & nbsp; & nbsp; & nbsp;

">

There is nothing fun about this mushroom that is a yeast.

Candida auris can, has, and continues to spread to hospitals around the world. It can stay long enough on skin and objects, such as furniture and hospital equipment. Thus, it can be transmitted indirectly from one patient to the other. It can invade your body and kill you if your immune system is weakened. It can be resistant to the three main classes of antifungal medications, leaving little choice for doctors to treat C. auris infections.

Therefore, candi-do not take lightly what the Centers for Disease Control and Prevention (CDC) have called it a "global emerging threat". To the yeast, learn more about this yeast.

To get an idea of ​​the difficulty Candida auris maybe, take a look at a study published last year in the journal Emerging infectious diseases. This study examined 51 cases of C. auris infections occurred in health facilities in New York from 2016 to 2018. All patients already had serious health problems prior to infection and were aged 21 to 96 years. Nearly half (45%) of the patients died within 90 days of diagnosis. C. auris infections. Almost all (98%) of C. auris samples from 50 patients were resistant to fluconazole, a commonly used antifungal drug. Testing different objects and rooms revealed C. auris in environments of 15 of the 20 health facilities.

Typically, C. auris infections occur after a patient in a health facility for several weeks. The most commonly reported infections include wounds, blood circulation and ears. Doctors have found the fungus in the urine and the respiratory tract of people, but it is unclear whether the fungus is hiding in these places without causing problems. For the moment, if your immune system is strong, your chances of having a vital risk C. auris infections are very low. The risk increases if you have a chronic illness like diabetes mellitus or have recently undergone surgery, recent antibiotic therapy or a central venous catheter. However, as Sarah Connor said in the terminator, the future is unknown. Who knows if one day C. auris will be a threat to healthy people too?

In June 2016, the CDC alerted health facilities about this growing threat. The first official case of C. auris, was held in Japan in 2009. Since then, C. auris has appeared in many countries, including South Korea, India, South Africa, Kuwait, Colombia, Venezuela, Pakistan, the United Kingdom and the United States.

The question is how much health facilities talk about their franchise. Candida auris problems? Not as sincere as they could be, according to what Matt Richtel and Andrew Jacobs wrote for the New York Times. Their article described what happened when the Royal Brompton Hospital in London realized that it had a C. auris problem in 2015. While the hospital had alerted the British government and infected patients, the hospital "made no public announcement". (At least, they told infected patients.) As Richtel and Jacobs write, "National and local institutions and governments have been reluctant to announce outbreaks of resistant infections, saying it was useless to do fear to patients – or potential. "

Uh, no need to scare patients? It's like saying that there is no point in letting people looking to look at Shazam know that there is currently a free tiger in a movie theater. You have the right to know something that can kill you or your loved ones. When choosing a health facility, the facility's ability to prevent and control infections should be a determining factor. After all, would you go to a pizzeria known for diarrhea while her pizza is delicious?

Health institutions may take measures to control the spread of C. auris. Detecting and diagnosing this fungus quickly is important. It's not always easy since C. auris can be confused with other types of candida species. Once a patient is diagnosed with C. auris, the health facility should place the patient in a separate room as soon as possible. Everyone entering the room should take precautions, including wearing disposable gloves and gowns. It is also essential that health care facilities with C. auris regularly cleanse and disinfect affected patients' rooms with special cleaning agents known to be effective against fungi. The Environmental Protection Agency (EPA) has a list of these cleaners.

Much of the fight against antimicrobial resistant organisms has been focused on antimicrobial bacteria. However, it is not enough to catch your bacteria. The emergence of drug-resistant C. auris is a reminder that other microbes can also become resistant to our available weapons. Candidiasis, in general, may be better known to cause diaper rash. Do not take a more urgent approach to deal with C. auris would not only be a rash, but would leave us immersed in what you often find in diapers.